Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Role of Antenatal Magnesium Sulphate in High-Risk Preterm Patients With Cerebral Palsy: a Randomized Clinical Trial

NCT07524972 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07524972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07524972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Role of Antenatal Magnesium Sulphate in High-Risk Preterm Patients With Cerebral Palsy: a Randomized Clinical Trial
Lead sponsor
Cairo University
Phase
Phase 3
Overall status
Recruiting
Start date
May 1, 2026
Completion date
May 30, 2028
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, magnesium sulfate overdose